| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 9254206 | Journal of Hepatology | 2005 | 7 Pages |
Abstract
The serial quantitation of serum anti-gp210-C-terminal peptide antibodies is useful for monitoring the effect of UDCA and for the early identification of patients at high risk for end-stage hepatic failure.
Related Topics
Health Sciences
Medicine and Dentistry
Gastroenterology
Authors
Minoru Nakamura, Yuki Shimizu-Yoshida, Yasushi Takii, Atsumasa Komori, Terufumi Yokoyama, Toshihito Ueki, Manabu Daikoku, Koji Yano, Takehiro Matsumoto, Kiyoshi Migita, Hiroshi Yatsuhashi, Masahiro Ito, Naohiko Masaki, Hiroshi Adachi, Yukio Watanabe,